Gobert D, Lidove O, de Fontbrune F Sicre, Peltier J, Chedid K, Burnat P, Perrier F, Chauveheid M-P, Papo T
Service de Médecine Interne, Hôpital Bichat, 46, rue Henri-Huchard, 75722 Paris cedex 18, France.
Rev Med Interne. 2007 Jul;28(7):507-9. doi: 10.1016/j.revmed.2007.02.004. Epub 2007 Mar 13.
End-stage renal failure patients are particularly at risk for tuberculosis, especially for peritoneal tuberculosis. Microbiological diagnosis remains hazardous in many cases.
We report on a case of peritoneal tuberculosis in an end-stage renal failure patient. The diagnosis was suspected on the basis of adenosine deaminase dosage in peritoneal fluid, allowing an early presumptive treatment and a favourable outcome with a 3 years follow-up.
The measurement of adenosine deaminase activity in ascites represents a diagnostic advance in tuberculous peritonitis among end-stage renal failure patients.
终末期肾衰竭患者患结核病的风险尤其高，特别是腹膜结核。在许多情况下，微生物学诊断仍然具有危险性。
我们报告一例终末期肾衰竭患者的腹膜结核病例。根据腹腔积液中腺苷脱氨酶的测定怀疑该诊断，从而得以进行早期推定治疗，并在3年随访中取得了良好结果。
腹水腺苷脱氨酶活性的测定代表了终末期肾衰竭患者结核性腹膜炎诊断方面的一项进展。
